Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neurofibromin 1 pseudogene 2 (NF1P2) is a non-processed pseudogene related to the NF1 gene and located on human chromosome 2[2][3]. It consists of DNA sequences highly homologous to parts of the NF1 gene but lacks protein-coding capacity, including critical functional domains, notably the GAP-related domain required for the neurofibromin protein’s Ras GTPase activity[2][3]. NF1P2 and closely related pseudogenes on chromosomes 14 and 22 likely arose during primate evolution by segmental duplication and transposition events. Unlike the functional NF1 gene, mutations or variation in NF1P2 have no known biological or clinical significance. NF1P2 is NOT a functional protein, receptor, or therapeutic target. It is a pseudogene (genomic remnant) with no evidence for expression, function, or druggability, and should NOT be confused with NF1, the protein-coding gene encoding the neurofibromin tumor suppressor[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neurofibromin 1 pseudogene 2 (NF1P2).